Sotera Health Company

NasdaqGS SHC

Sotera Health Company Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2024: 6.81%

Sotera Health Company Return on Capital Employed (ROCE) is 6.81% for the Trailing 12 Months (TTM) ending September 30, 2024, a 191.20% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Sotera Health Company Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2023 was -7.47%, a -177.90% change year over year.
Sotera Health Company Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2022 was 9.59%, a 8.85% change year over year.
Sotera Health Company Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2021 was 8.81%.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

NasdaqGS: SHC

Sotera Health Company

CEO	Mr. Michael B. Petras Jr.
IPO Date	Nov. 20, 2020
Location	United States
Headquarters	9100 South Hills Boulevard
Employees	3,000
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

Key trends

Past 5 years